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Objective: Laparoendoscopic single-site surgery (LESS) is a new laparoscopy development that avoids the
use of multiple ports and minimizes morbidity. Combined with retroperitoneoscopy, LESS is suitable for
adrenalectomy. We compared open, conventional laparoscopic, and LESS-retroperitoneoscopic adrenal-
ectomy (LESS-RA) surgeries for adrenal tumor removal. Furthermore, we analyzed the conventional
retroperitoneoscopic adrenalectomy (CRA) and LESS-RA outcomes.
Materials and Methods: We examined 178 patients who underwent adrenalectomy: 43 by open surgery,
72 by conventional laparoscopy, and 63 by LESS-RA. We analyzed the outcomes of operative time,
estimated blood loss (EBL), complications, postoperative convalescence, time to resuming oral intake,
analgesics on demand, and hospital stay.
Results: We found that the open surgery group had a signiﬁcantly greater mean EBL than the conven-
tional laparoscopy or LESS-RA group (353.1± 313.6 mL vs. 62.3± 76.9 mL vs. 60.9± 64.3 mL, respectively;
p< 0.0001). Open surgery was lengthier than LESS-RA. Both hospital stay and time to resuming oral
intake were shortest in the LESS-RA group, followed by conventional laparoscopy and open surgery. CRA
and LESS-RA did not differ signiﬁcantly in mean tumor size, operation time, or EBL. However, there were
signiﬁcant differences in postoperative hospital stay length (6.4± 3.4 days vs. 3.6± 1.3 days, respectively;
p< 0.0001), time to resuming oral intake (1.2± 0.5 days vs. 0.4± 0.5 days, respectively; p< 0.0001), and
number of on-demand intravenous or intramuscular analgesics needed (0.5± 0.8 ampoules/vial vs.
0.3± 0.6 ampoules/vial, respectively; p¼ 0.0484).
Conclusion: The standard approach to adrenalectomy recently improved from open to laparoscopic
surgery, transperitoneal to retroperitoneal access, and multiple ports to a single port. Here we found that
laparoscopic surgery had better intra- and postoperative outcomes than open surgery. Furthermore,
patients treated with LESS-RA required less postoperative recovery time and less analgesic use than
those treated with CRA.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Laparoscopic surgery has been shown to result in faster recovery
and convalescence, less postoperative morbidity, and betteraohsiung Municipal Ta-Tung
ohsiung Medical University,
.
ociation. Published by Elsevier Ta
S-H, et al., Laparoendoscop
, Urological Science (2016), hcosmesis than open procedures,1 and it has now practically
replaced open surgery in the management of adrenal lesions. Most
surgeons agree that it currently represents the standard approach
to adrenalectomy.2
As a technical development, the retroperitoneal approach has
become popular among urologists for its rapid access to the kidney,
renal hilum, and adrenal gland in the retroperitoneal space
together with the reduced risk of intra-abdominal organ injury,
bowel adhesions, and postoperative ileus.3 Thus, many studies oniwan LLC. This is an open access article under the CC BY-NC-ND license (http://
ic single-site retroperitoneoscopic adrenalectomy compared with
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Figure 1. Trocar wounds of a conventional transperitoneoscopic left adrenalectomy
procedure.
S.-H. Chen et al. / Urological Science xxx (2016) 1e62retroperitoneoscopic adrenalectomy have been published over the
past few decades.
The novel laparoendoscopic single-site surgery (LESS) is a
further development of laparoscopy in an attempt to prevent
multiple scars4 and minimize port-related morbidities such as
bleeding, pain, hernia, and internal organ damage.5 Many urologi-
cal procedures have been developed and demonstrated to be
feasible and safely performed using LESS. A combination of LESS
and retroperitoneoscopic adrenalectomy could be a novel surgery
with safer and better outcomes.
In this study, we compared the outcomes of patients undergoing
open, conventional laparoscopic surgery with those undergoing
LESS-retroperitoneoscopic adrenalectomy (LESS-RA). We also
evaluated the results of conventional retroperitoneoscopic adre-
nalectomy (CRA) and LESS-RA performed by a single surgeon.
2. Materials and methods
Between November 2001 and April 2014, 178 patients with
adrenal lesions underwent surgical treatment at Kaohsiung Medi-
cal University Hospital, Kaohsiung Municipal Ta-Tung Hospital, and
Kaohsiung Municipal Hsiao-Kang Hospital in Kaohsiung, Taiwan.
We performed 43 open retroperitoneal adrenalectomy pro-
cedures (Group 1), 72 conventional laparoscopic adrenalectomy
procedures including intra- and extraperitoneal approaches (Group
2), and 63 LESS-RA procedures (Group 3). The conventional lapa-
roscopic and LESS-RA procedures were performed by a single
surgeon.
If the adrenal tumors were> 6 cm, we performed a traditional
open retroperitoneal adrenalectomy or a laparoscopic trans-
peritoneal adrenalectomy to ensure a wider operative ﬁeld. These
two different surgical approaches were mainly decided by the
surgeon's experience and the expense that the patient could
manage. If the patient had undergone a previous intra-abdominal
surgery, we preferred the retroperitoneal approach. For the lapa-
roscopic retroperitoneal surgery, we used the traditional laparo-
scopic retroperitoneal approach (3 trocar wounds) early on in the
study period according to the devices available at each hospital, and
then changed to LESS after the introduction of the single-port de-
vice and the 5-mm camera scope.
In this study, we collected intraoperative [estimated blood loss
(EBL) and operative time] and postoperative (time to resuming oral
intake and postoperative stay length) parameters for analysis.
During postoperative care, the regular administration of oral
diclofenac (25 mg t.i.d.) or acetaminophen (500 mg t.i.d.) was
recorded. In addition, data on all parenterally administered anal-
gesics during admission were collected, including nalbuphine,
pethidine, morphine, fentanyl, and ketorolac. The total number of
ampoules/vial required by the patient during the hospital stay was
calculated. Except for open retroperitoneal adrenalectomy, patients
were able to ambulate on the day of the surgery. The patients were
discharged when their pain and oral intake were tolerable.
2.1. Laparoscopic operative technique
The conventional transperitoneoscopic adrenalectomy was
started with the patient in the standard 60 lateral decubitus po-
sition with elevation of the kidney rest and a minimally ﬂexed
operation table. The ﬁrst 12-mm port was inserted in the peri-
umbilical area to accommodate the camera. Two subcostal ports
were placed: one (11 mm, right hand) in the midclavicular line and
the other (5 mm, left hand) in the lateral border of the rectus
abdominis muscle. The third (5 mm, retractor) subcostal trocar was
inserted into the anterior axillary line (Figure 1). One must avoid
placing these ports too closely together.Please cite this article in press as: Chen S-H, et al., Laparoendoscop
conventional laparoscopy and open surgery, Urological Science (2016), hStandard straight laparoscopic instruments, 5-mm endoclips,
and a vessel-sealing system (Harmonic Scalpel; Ethicon Inc.) were
used for the manipulation and dissection.
The initiation of the left adrenalectomy, as discussed here, re-
quires incising along thewhite line of Toldt from the splenic ﬂexure
to the sigmoid junction to allowmobilization of the left colon. After
opening Gerota's fascia, we dissected and freed the adrenal gland,
including the adrenal arteries, using a dissector and harmonic
scalpel.While the adrenal veinwas identiﬁed, we used a Hem-o-lok
for the ligation. Finally, we removed the adrenal tumor from the
periumbilical wound and placed a drainage tube at the subcostal
wound.
The CRA started with the patient in the standard 90 full ﬂank
position with elevation of the kidney rest and a minimally ﬂexed
operation table. The surgeon and assistant stood behind the patient
during the surgery. A 2-cm transverse skin incision was created
2 cm above the iliac crest along the midaxillary line. The working
space was created using a balloon dilator. Under direct vision by a
30 laparoscope, two secondary laparoscopic ports (an 11-mm
trocar and a 5-mm trocar) were placed slightly under the costal
margin along the posterior and anterior axillary lines, respectively
(Figure 2; Lines 1e3). After we pushed down the retroperitoneal fat
and incised the Gerota's fascia, the procedure was the same as that
followed for the transperitoneal laparoscopy except for placement
of the drainage tube. The adrenal tumor was removed from the 2-
cm wound above the iliac crest.
For the LESS-RA, moving from a 10- to 5-mm rigid 30 laparo-
scope created a smaller wound. The LESS-RA started with the pa-
tient in the ﬂank positionwith the affected side elevated to 90, and
the surgeon and assistant stood facing the patient's back. A 2.5-cm
skin incision was made just below the 12th rib in the posterior
axillary line (Figure 2; Line 4). We then accessed the retroperitoneal
space through the exposed thoracolumbar fascia. After we used a
balloon dilator to create the retroperitoneal space, the procedureic single-site retroperitoneoscopic adrenalectomy compared with
ttp://dx.doi.org/10.1016/j.urols.2016.05.001
Figure 2. Trocar wounds of a conventional retroperitoneoscopic left adrenalectomy
procedure (Lines 1e3); incision wound of the laparoendoscopic single-site retro-
peritoneoscopic left adrenalectomy (Line 4).
Figure 4. The 2.5-cm incision wound resulting from the laparoendoscopic single-site
retroperitoneoscopic adrenalectomy.
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tumor was removed from the LESS-RA wound.
In the early days of LESS-RA, an Alexis wound retractor (Xsmall;
Applied Medical, Rancho Santa Margarita, CA, USA) with home-
made sterile surgical glove combining two 10-mm and one 5-mm
laparoscopic standard trocars, which was made by the surgeon
himself, was used (Figure 3A). Later, a GelPOINT (Figure 3B) was
brought in and replaced the endoscopic instruments. Because of
the restriction of time-limited usage of GelPOINT, a LAGIPORT set
(Figure 3C) was used for entry. Figure 4 shows the 2.5-cm incision
wound resulting from the LESS-RA.
2.2. Outcome variables and statistical analysis
The data collected from both groups included age, sex, body
mass index (BMI), adrenal tumor laterality, tumor size, operative
time, EBL, time to resuming oral intake (days), tumor size, intra-
venous (IV) or intramuscular (IM) analgesics on demand, and
postoperative hospital stay length.
The statistical analysis was performed using SAS version 9.2 for
Windows (SAS Institute Inc., Cary, NC, USA). An alpha level of 0.05Figure 3. Evolution of the wound retractor used for laparoendoscopic single-site retroperit
wound retractor was used. The commercial GelPOINT wound retractor (B) was eventually
previous devices due to its advantages of reusability and tight seal.
Please cite this article in press as: Chen S-H, et al., Laparoendoscop
conventional laparoscopy and open surgery, Urological Science (2016), hwas considered signiﬁcant for all of the statistical procedures. The
characteristics of the study participants were presented as mean-
s± standard deviation for normally distributed variables, medians
with 25the75th percentiles for non-normally distributed variables,
and frequencies for categorical variables. For the p values, com-
parisons between the hospitals were performed using analyses of
variance, Wilcoxon ranked sum test, or t test. For the categorical
variables, the c2 or Fisher's exact test was performed as
appropriate.
3. Results
The patients' characteristics are summarized in Table 1. There
were no signiﬁcant differences in age, sex, BMI, laterality, or
pathological diagnosis of the adrenal tumor among the three
groups except for adrenal tumor size. The open approach group had
a larger mean tumor size than the conventional laparoscopy and
LESS-RA groups (5.8± 3.7 cm vs. 3.7± 1.6 cm vs. 4.0± 1.6 cm,
respectively; p< 0.0001). We also performed a subgroup analysis of
the whole retroperitoneal laparoscopy approach, including CRA
and LESS-RA, and the patient demographic data are outlined in
Table 2. Tumor size did not differ signiﬁcantly between the two
groups.
The peri- and postoperative outcomes are summarized in
Table 3. Signiﬁcant differences were seen among the three groupsoneoscopic adrenalectomy. When the procedure was ﬁrst performed, (A) a homemade
brought in. Most recently, the LAGIPORT wound retractor (C) has taken the place of
ic single-site retroperitoneoscopic adrenalectomy compared with
ttp://dx.doi.org/10.1016/j.urols.2016.05.001
Table 1
Baseline characteristics of patients according to the surgical procedure for
adrenalectomy.
Open
adrenalectomy
CLA LESS-RA p
No. of patients 43 72 63
Age (SD), y 47.3 (14.8) 47.5 (12.5) 50.3 (11.9) 0.3739
Sex, n (%)
Male 17 (39.5) 28 (38.9) 30 (47.6)
Female 26 (60.5) 44 (61.1) 33 (52.4) 0.5468
Tumor side, n (%)
Left 19 (46.3) 38 (52.8) 37 (58.7)
Right 22 (53.7) 34 (47.2) 26 (41.3) 0.4604
BMI (SD), kg/m2 25.8 (5.0) 25.0 (4.5) 24.9 (3.6) 0.9166
Tumor size (SD), cm 5.8 (3.7) 3.7 (1.6) 4.0 (1.6) <0.0001
Pathologic diagnosis, n (%)
Conn's disease 6 (14.0) 32 (44.4) 36 (58.1)
Cushing syndrome 8 (18.6) 9 (12.5) 5 (8.1)
Pheochromocytoma 10 (23.3) 7 (9.7) 2 (3.2)
NFAM 6 (14.0) 17 (23.6) 16 (25.8)
Malignant 4 (9.3) 1 (1.4) 0 (0.0)
Others a 9 (20.9) 6 (8.3) 3 (4.8) <0.0001
BMI¼ body mass index; CLA¼ conventional laparoscopic adrenalectomy; LESS-
RA¼ laparoendoscopic single-site retroperitoneoscopic adrenalectomy;
NFAM¼ nonfunctioning adrenal masses; SD¼ standard deviation.
a Others included ganglioneuroma, myelolipoma, and schwannoma.
Table 2
Baseline characteristics of patients according to laparoendoscopic retroperitoneal
adrenalectomy.
CRA LESS-RA p
No. of patients 54 63
Age (SD), y 48.5 (12.6) 50.3 (11.9) 0.5073
Sex, n (%)
Male 22 (40.7) 30 (47.6)
Female 32 (59.3) 33 (52.4) 0.4554
Tumor side, n (%)
Left 28 (51.9) 37 (58.7)
Right 26 (48.1) 26 (41.3) 0.4554
Tumor size (SD), cm 3.5 (1.3) 4.0 (1.6) 0.0745
Pathologic diagnosis, n (%)
Conn's disease 30 (55.6) 36 (58.1)
Cushing syndrome 7 (13.0) 5 (8.1)
Pheochromocytoma 1 (1.9) 2 (3.2)
NFAM 12 (22.2) 16 (25.8)
Malignant 1 (1.9) 0 (0.0)
Othersa 3 (5.6) 3 (4.8) 0.8811
CRA¼ conventional retroperitoneoscopic adrenalectomy; LESS-RA¼ laparoendo-
scopic single-site retroperitoneoscopic adrenalectomy; NFAM¼ nonfunctioning
adrenal masses; SD¼ standard deviation.
a Others included ganglioneuroma, myelolipoma, and schwannoma.
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minutes vs. 115.7 minutes in open, conventional laparoscopy, and
LESS-RA, respectively; p¼ 0.02) andmean EBL (353.1± 313.6 mL vs.
62.3± 76.9 mL vs. 60.9± 64.3 mL, respectively; p< 0.0001). Con-
cerning postoperative parameters, the mean postoperative hospital
stay length (9.5± 3.1 days vs. 6.4± 3.0 days vs. 3.6± 1.3 days,
respectively; p< 0.0001) and themean time to resuming oral intake
(2.2± 0.8 days vs. 1.3± 0.6 days vs. 0.4± 0.5 days, respectively;Table 3
Perioperative and postoperative outcomes of the surgical procedures.
Open
Mean (SD)
Estimated blood loss (mL) 353.1 (313.6)
Operation time (min) 140.5 (59.4)
Postoperative stays (d) 9.5 (3.1)
Time to resume oral intake (d) 2.2 (0.8)
CLA¼ conventional laparoscopic adrenalectomy; LESS-RA¼ laparoendoscopic single-site
Please cite this article in press as: Chen S-H, et al., Laparoendoscop
conventional laparoscopy and open surgery, Urological Science (2016), hp< 0.0001) were signiﬁcantly different. In the post hoc analysis, we
found that the open surgery group had a higher EBL than the con-
ventional laparoscopy and LESS-RA groups. Regarding operative
time, the open procedure group required more time than the LESS-
RA group. In terms of convalescence, both hospital stay and time to
resuming oral intakewere similar with LESS-RA having the shortest
stay, followed by conventional laparoscopy and open surgery.
An analysis of the conventional laparoscopic and LESS-RA
(Table 4) subgroups revealed no signiﬁcant difference in the
mean operation time (122.7 minutes vs. 115.7 minutes in conven-
tional retroperitoneoscopy vs. LESS-RA, respectively; p¼ 0.3518),
mean EBL (47.3± 56.1 mL vs. 60.9± 64.3 mL, respectively;
p¼ 0.23070), and mean tumor size (3.5± 1.3 cm vs. 4.0± 1.6 cm,
respectively; p¼ 0.0745). However, there were signiﬁcant differ-
ences in mean postoperative hospital stay length (6.4± 3.4 days vs.
3.6± 1.3 days, respectively; p< 0.0001), time to resuming oral
intake (1.2± 0.5 days vs. 0.4± 0.5 days, respectively; p< 0.0001),
and mean number of on-demand IV or IM analgesics (0.5± 0.8
ampoules/vial vs. 0.3± 0.6 ampoules/vial, respectively; p¼ 0.0484).
No conversions to the open approach from the conventional
retroperitoneoscopic approach were necessary, and no cases of
blood transfusion or mortality occurred in the CRA or LESS-RA
group.4. Discussion
Laparoscopy has become the gold standard surgery for adre-
nalectomy. Compared with the open approach, laparoscopic adre-
nalectomy reportedly has less operative blood loss and a lower
need for blood transfusion. It also requires parenteral analgesics
and features a shorter hospital stay and faster return to daily ac-
tivities and work.6
Laparoscopic adrenalectomy can be performed by the trans-
abdominal (intraperitoneal) or lumbar (retroperitoneal) approach.
We found no signiﬁcant differences in perioperative or post-
operative parameters such as operative time, analgesic dosing re-
quirements, hospital stay, and time to return to normal activities.7
However, compared with the transabdominal approach, the lum-
bar approach avoided the effects of CO2 pneumoperitoneum, which
might cause respiratory and hemodynamic changes, and allowed us
to enter the Gerota's fascia from the retroperitoneum without
touching the intra-abdominal visceral organs. The challenge of the
retroperitoneal approach includes abundant and poorly distensible
retroperitoneal fat, which impedes the creation of an adequate
working space in the retroperitoneum and makes it difﬁcult to
maintain orientation in the retroperitoneumdue to the lack of visual
anatomical landmarks that are normally surrounded by retroperi-
toneal fat.8
In recent years, a novel surgical technique, LESS, was developed
for the purposes of minimizing wound size and reducing morbidity.
LESS access could be obtained using a single skin and fascial inci-
sion through which a single multichannel access platform is placed
(single port) or by the placement of several low-proﬁle ports
through separate fascial incisions (single site).9 The former isCLA LESS-RA p
Mean (SD) Mean (SD)
62.3 (76.9) 60.9 (64.3) <0.0001
133.3 (51.9) 115.7 (29.4) 0.0206
6.4 (3.0) 3.6 (1.3) <0.0001
1.3 (0.6) 0.4 (0.5) <0.0001
retroperitoneoscopic adrenalectomy; SD¼ standard deviation.
ic single-site retroperitoneoscopic adrenalectomy compared with
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Table 4
Comparison of outcomes between the conventional laparoscopic and LESS-RA procedures.
CRA LESS-RA p
Mean (SD) Mean (SD)
Estimated blood loss (mL) 47.3 (56.1) 60.9 (64.3) 0.2307
Operation time (min) 122.7 (50.3) 115.7 (29.4) 0.3518
Postoperative stays (d) 6.4 (3.4) 3.6 (1.3) <0.0001
Time to resume oral intake (d) 1.2 (0.5) 0.4 (0.5) <0.0001
Intravenous or intramuscular analgesics (ampoules/vial) 0.5 (0.8) 0.3 (0.6) 0.0484
CRA¼ conventional retroperitoneoscopic adrenalectomy; LESS-RA¼ laparoendoscopic single-site retroperitoneoscopic adrenalectomy; SD¼ standard deviation.
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LESS procedure is to use a single-access port that allows the
simultaneous passage of multiple laparoscopic instruments.10 The
ﬁrst two large series of urological LESS procedures published in
200910,11 revealed that LESS was not inferior to conventional lap-
aroscopy and was feasible for urological surgery. This method is
now well developed and feasible for a variety of urological
operations.
LESS surgery can be technically difﬁcult because of limitations
triangulating the instrument positions. Because all instruments
enter through the single port, the surgeon and assistant work in a
small space.12 In a previous retrospective analysis, LESS was not
found to be superior to laparoscopy.13 The reasons for this included
difﬁculty crossing manipulation, instrument ﬁghting, and novel
skillswith steep learning curve.14 These factors could be challenging
for inexperienced surgeons. Despite these limitations, LESS had its
own advantage, including a small incision wound, fewer trocar-
related complications, and increased patient safety. The ﬁrst suc-
cessful LESS adrenalectomy was published by Cindolo et al15 using
the transperitoneal approach. Subsequently, several studies of LESS
adrenalectomyhave been reported,which shows that this surgery is
becomingmorewidespread.16,17 In the present series, the umbilicus
was the most frequently chosen access site for LESS because it has
the better cosmetic outcome. However, it was difﬁcult to perform
becausemultiple instruments share a small space and there is a long
distance fromthe incisionwound to theadrenal gland,which caused
the limited angle of the instrument'smovement and the approach to
become increasingly tangential.18 Accordingly, we used retroperi-
toneal LESS for the adrenalectomy because it features shorter and
safer access. In addition, the retroperitoneal approach was not
obstructed by previous abdominal surgery, and the tumor size was
the main determinant of wound size. Although some articulating
instruments were available to create more working space, we still
used conventional instruments for economic reasons.
Because LESS-RA was performed by experienced laparoscopic
surgeons in our study, the risk of complications remained low. The
conventional laparoscopic and LESS-RA groups had signiﬁcantly
less mean blood loss than the open approach, and none of the
patients in these groups needed a blood transfusion during
admission. The Clavien system complications in the conventional
laparoscopic and LESS-RA groupswere not greater than Grade 1. For
the aforementioned reasons, laparoscopy has become the gold
standard procedure for adrenalectomy.19 For the retroperitoneal
laparoscopic adrenalectomy, we did not perform drainage after
operation due to the small amount of blood loss. Severewound pain
was rare and the patients required less than a mean of one
parenteral analgesic dose during admission.
As in retroperitoneal adrenalectomy, we found that LESS-RA has
greater beneﬁts than CRA from several points of view. There are
two reasons as towhy operative time did not increase in LESS-RA in
our study. First, the incision wound of LESS-RA is close to the ad-
renal gland at the subcostal area from the retroperitoneum. Thus,
less time is required to dissect the retroperitoneal fat and identifyPlease cite this article in press as: Chen S-H, et al., Laparoendoscop
conventional laparoscopy and open surgery, Urological Science (2016), hthe adrenal gland. Second, the conventional laparoscopic and LESS-
RA procedures were performed by a single surgeon with extensive
laparoscopic skill, which shortened the learning curve for technical
conversion.
Although no drainage tube was placed in patients treated with
CRA or LESS-RA, the total mean size of the surgical wound was
smaller in the LESS-RA group. We found that the postoperative
parenteral analgesics signiﬁcantly decreased in the LESS-RA group
during admission, which was different from the results of a previ-
ous report.20 The major reasonwas that this study had an increased
number of cases in the subgroups analysis. Several published
studies reported similar results of less postoperative pain for pa-
tients treated with LESS-RA.11,21
Several published reports showed that patients treated with
laparoscopic surgery required less time to resume oral feeding than
those treated with open surgery,22 whereas those treated with the
retroperitoneal approach resumed oral intake sooner than those
treated with the transperitoneal approach.23 Our study also pre-
sented a similar result: patients treated with retroperitoneal LESS-
RA required less time to resume oral intake than those treated with
the retroperitoneal laparoscopic approach. The reason for this
could be that, although both procedures approach the adrenal
gland by balloon dilatation and the instrument dissecting the
retroperitoneal fat, the laparoscopic approach requires a wider
dissection area and more working space, which might affect the
colon peristalsis. The LESS-RA port location was just beneath the
12th rib to avoid direct contact with the colon. The major concern of
time to oral intake in these patients was the anesthetic degrade
instead of recovery of bowel peristalsis.
There are some limitations of our study. First, the sample sizes in
all groups were small, so further studies with larger populations are
needed to compare the procedural effects and outcomes. Second,
the ports over the incision wound in the LESS-RA surgery differ,
which could inﬂuence perioperative parameters such as operative
time. Third, the parenteral analgesics were not standardized,
meaning that every administration dose had a different pain relief
effect. We also did not subgroup the patients by adrenal adenoma
type for analysis, and these can inﬂuence complication (e.g.,
pheochromocytoma and Cushing disease), operation time, and
hospital stay; besides, it would also need gradual steroid tapering.
Finally, in this study, although laparoscopic operations were per-
formed by a single surgeon, the open adrenalectomy was per-
formed by different surgeons. This is the limitation of our study.
Our initial experience shows that LESS-RA is feasible and safe for
the treatment of adrenal tumors. Laparoscopy has superior intra-
operative and postoperative outcomes to those of open adrenal-
ectomy. Furthermore, compared with CRA, LESS-RA has better
postoperative outcomes, including time to oral intake, analgesic
use, convalescence, and cosmetic results.
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